Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Usefulness of Amiodarone for the Prevention of New Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: a Randomized Controlled Trial

NCT03991754 is registered in ClinicalTrials.gov with Ana Belen Rivas Paterna as lead sponsor.

NCT NCT03991754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03991754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Usefulness of Amiodarone for the Prevention of New Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: a Randomized Controlled Trial
Lead sponsor
Ana Belen Rivas Paterna
Phase
Phase 3
Overall status
Completed
Start date
January 30, 2020
Completion date
June 13, 2023
Enrollment
121 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation new onset